Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Drop in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIXGet Free Report) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 46,800 shares, a drop of 53.3% from the October 31st total of 100,200 shares. Currently, 7.5% of the company’s stock are short sold. Based on an average daily volume of 504,700 shares, the days-to-cover ratio is presently 0.1 days.

Autonomix Medical Stock Down 10.4 %

NASDAQ:AMIX traded down $0.57 during trading hours on Friday, reaching $4.92. 263,940 shares of the stock were exchanged, compared to its average volume of 226,942. The stock has a market cap of $5.66 million and a PE ratio of -0.32. Autonomix Medical has a twelve month low of $4.82 and a twelve month high of $152.00. The firm has a 50 day moving average of $10.99 and a 200 day moving average of $19.17. The company has a debt-to-equity ratio of 0.36, a current ratio of 4.26 and a quick ratio of 4.26.

Wall Street Analyst Weigh In

Separately, LADENBURG THALM/SH SH started coverage on Autonomix Medical in a report on Tuesday, September 3rd. They issued a “buy” rating and a $28.00 price target on the stock.

Check Out Our Latest Analysis on Autonomix Medical

About Autonomix Medical

(Get Free Report)

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.

Read More

Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.